Presentation is loading. Please wait.

Presentation is loading. Please wait.

Long-term Low-Molecular-Weight Heparin versus Usual Care in Proximal-Vein Thrombosis Patients with Cancer  Russell D. Hull, MBBS, MSc, Graham F. Pineo,

Similar presentations


Presentation on theme: "Long-term Low-Molecular-Weight Heparin versus Usual Care in Proximal-Vein Thrombosis Patients with Cancer  Russell D. Hull, MBBS, MSc, Graham F. Pineo,"— Presentation transcript:

1 Long-term Low-Molecular-Weight Heparin versus Usual Care in Proximal-Vein Thrombosis Patients with Cancer  Russell D. Hull, MBBS, MSc, Graham F. Pineo, MD, Rollin F. Brant, PhD, Andrew F. Mah, BSc, Natasha Burke, BSc, Richard Dear, MD, Turnly Wong, MD, Roy Cook, MD, Susan Solymoss, MD, Man-Chiu Poon, MD, MSc, Gary Raskob, PhD  The American Journal of Medicine  Volume 119, Issue 12, Pages (December 2006) DOI: /j.amjmed Copyright © 2006 Elsevier Inc. Terms and Conditions

2 Figure 1 Participant flow chart.
The American Journal of Medicine  , DOI: ( /j.amjmed ) Copyright © 2006 Elsevier Inc. Terms and Conditions

3 Figure 2 Time to event analysis for patients who had recurrent venous thromboembolism. The American Journal of Medicine  , DOI: ( /j.amjmed ) Copyright © 2006 Elsevier Inc. Terms and Conditions

4 Figure 3 Time to event analysis for patients who died.
The American Journal of Medicine  , DOI: ( /j.amjmed ) Copyright © 2006 Elsevier Inc. Terms and Conditions

5 Figure 4 Randomized clinical trials of long-term low-molecular-weight heparin therapy combined with vitamin-k-antagonist therapy in cancer patients with venous thromboembolism. The American Journal of Medicine  , DOI: ( /j.amjmed ) Copyright © 2006 Elsevier Inc. Terms and Conditions


Download ppt "Long-term Low-Molecular-Weight Heparin versus Usual Care in Proximal-Vein Thrombosis Patients with Cancer  Russell D. Hull, MBBS, MSc, Graham F. Pineo,"

Similar presentations


Ads by Google